Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric P. Lefkofsky sold 476,209 shares of the stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the sale, the chief executive officer now directly owns 6,502,643 shares of the company's stock, valued at approximately $324,091,727.12. This trade represents a 6.82 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
TEM traded down $3.44 during trading on Friday, reaching $51.40. The company had a trading volume of 12,994,864 shares, compared to its average volume of 9,294,415. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The business has a 50 day simple moving average of $44.38 and a 200-day simple moving average of $47.46. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $79.49.
TEM has been the topic of a number of research reports. Wolfe Research started coverage on shares of Tempus AI in a report on Friday, December 13th. They issued an "outperform" rating and a $60.00 price target on the stock. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They issued a "buy" rating and a $74.00 target price on the stock. Bank of America raised their price target on Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a report on Friday, December 13th. Needham & Company LLC reaffirmed a "buy" rating and set a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Finally, Loop Capital lowered their target price on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research report on Tuesday, January 14th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, Tempus AI presently has an average rating of "Moderate Buy" and a consensus price target of $56.36.
Read Our Latest Stock Report on Tempus AI
Several institutional investors have recently made changes to their positions in TEM. abrdn plc bought a new stake in shares of Tempus AI during the 4th quarter worth approximately $2,784,000. Renaissance Capital LLC increased its stake in Tempus AI by 121.3% in the fourth quarter. Renaissance Capital LLC now owns 24,757 shares of the company's stock worth $836,000 after purchasing an additional 13,569 shares during the period. China Universal Asset Management Co. Ltd. bought a new stake in shares of Tempus AI during the fourth quarter worth $1,091,000. Exchange Traded Concepts LLC boosted its stake in shares of Tempus AI by 37.8% during the fourth quarter. Exchange Traded Concepts LLC now owns 84,174 shares of the company's stock valued at $2,842,000 after purchasing an additional 23,070 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in shares of Tempus AI during the fourth quarter valued at $372,000. Institutional investors own 24.22% of the company's stock.
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.